Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study
- PMID: 26240760
- PMCID: PMC4512603
- DOI: 10.1155/2015/487159
Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study
Abstract
Depression and anxiety are reported to be prevalent in patients with MS, with prevalence rates ranging from 20% to 50%. Unfortunately, the rates, patterns, and risk factors are not well studied in our Middle East region, and, to our knowledge, not at all in UAE. Using standardized screening tools, we observed that 17% and 20% of 80 patients seen in MS clinic had scores consistent with major depression and anxiety disorders, respectively, at a rate that was not statistically different when compared to age and sex matched controls. None of the studied variables including duration of the disease, EDSS scores, age, gender, and the level of education had any significant correlation with the rates of both disorders. Almost two-thirds of the patients with scores consistent with major depression and anxiety were not on antidepressant and antianxiety medications.
Similar articles
-
Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study.Behav Neurol. 2015;2015:196373. doi: 10.1155/2015/196373. Epub 2015 Oct 21. Behav Neurol. 2015. PMID: 26576071 Free PMC article.
-
Prevalence of depression and anxiety among patients with epilepsy attending the epilepsy clinic at Sheikh Khalifa Medical City, UAE: A cross-sectional study.Epilepsy Behav. 2015 Nov;52(Pt A):194-9. doi: 10.1016/j.yebeh.2015.09.008. Epub 2015 Oct 5. Epilepsy Behav. 2015. PMID: 26448591
-
Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates.Neurol Int. 2017 Dec 11;9(4):7343. doi: 10.4081/ni.2017.7343. eCollection 2017 Dec 11. Neurol Int. 2017. PMID: 29619159 Free PMC article.
-
Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis.J Neurol Sci. 2017 Jan 15;372:331-341. doi: 10.1016/j.jns.2016.11.067. Epub 2016 Nov 30. J Neurol Sci. 2017. PMID: 28017241 Review.
-
Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis.Ment Illn. 2010 May 14;2(1):e5. doi: 10.4081/mi.2010.e5. eCollection 2010 Jan 25. Ment Illn. 2010. PMID: 25478088 Free PMC article. Review.
Cited by
-
Assessment of factors associated with depression and anxiety among pwMS in Saudi Arabia.BMC Neurol. 2022 Mar 25;22(1):120. doi: 10.1186/s12883-022-02632-2. BMC Neurol. 2022. PMID: 35337277 Free PMC article.
-
Prevalence of Anxiety and Depression in Patients With Multiple Sclerosis in Saudi Arabia: A Cross-Sectional Study.Cureus. 2021 Dec 29;13(12):e20792. doi: 10.7759/cureus.20792. eCollection 2021 Dec. Cureus. 2021. PMID: 34993046 Free PMC article.
-
Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study.Brain Behav. 2022 May;12(5):e2596. doi: 10.1002/brb3.2596. Epub 2022 Apr 22. Brain Behav. 2022. PMID: 35452562 Free PMC article.
-
Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study.Behav Neurol. 2015;2015:196373. doi: 10.1155/2015/196373. Epub 2015 Oct 21. Behav Neurol. 2015. PMID: 26576071 Free PMC article.
-
The Prevalence and Association of Depression and Anxiety With Multiple Sclerosis in Riyadh, Saudi Arabia: A Cross-Sectional Study.Cureus. 2020 Dec 30;12(12):e12389. doi: 10.7759/cureus.12389. Cureus. 2020. PMID: 33532152 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources